Status:
COMPLETED
The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects
Lead Sponsor:
Pfizer
Conditions:
Overactive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary Incontinence
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study is designed to estimate the effect of fluconazole (200 mg BID for 2 days), a moderate CYP3A4 inhibitor on the pharmacokinetics of a single 8 mg oral dose of fesoterodine in healthy adult su...
Eligibility Criteria
Inclusion
- Healthy subjects between the ages of 18 and 55 years
Exclusion
- Not healthy subjects. subjects with acute or chronic medical or psychiatric condition or laboratory abnormality
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00911235
Start Date
May 1 2009
End Date
July 1 2009
Last Update
June 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511